{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:41:09Z","timestamp":1789684869006,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08201-2","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:13:38Z","timestamp":1778166818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell profiling uncovers a hypoxia-vascular-immune axis underlying poor immunotherapy response in acral versus cutaneous melanoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Qian","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-6662","authenticated-orcid":false,"given":"Aihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"12","key":"8201_CR1","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1158\/2159-8290.CD-22-0603","volume":"12","author":"F Newell","year":"2022","unstructured":"Newell F, Johansson PA, Wilmott JS, Nones K, Lakis V, Pritchard AL, et al. Comparative genomics provides etiologic and biological Insight into melanoma subtypes. Cancer Discov. 2022;12(12):2856\u201379. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0603.","journal-title":"Cancer Discov"},{"issue":"1","key":"8201_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaad.2019.11.021","volume":"83","author":"MB Lobl","year":"2020","unstructured":"Lobl MB, Santos C, Clarey D, Higgins S, Silva-Lopez E, Sutton A, et al. Treatments and associated outcomes of acral lentiginous melanoma: a review. J Educ Chang Am Acad Dermatol. 2020;83(1):230\u201334. https:\/\/doi.org\/10.1016\/j.jaad.2019.11.021.","journal-title":"J Educ Chang Am Acad Dermatol"},{"issue":"7653","key":"8201_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175\u201380. https:\/\/doi.org\/10.1038\/nature22071.","journal-title":"Nature"},{"issue":"1","key":"8201_CR4","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","volume":"11","author":"F Newell","year":"2020","unstructured":"Newell F, Wilmott JS, Johansson PA, Nones K, Addala V, Mukhopadhyay P, et al. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun. 2020;11(1):5259. https:\/\/doi.org\/10.1038\/s41467-020-18988-3.","journal-title":"Nat Commun"},{"issue":"20","key":"8201_CR5","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1158\/1078-0432.CCR-17-0980","volume":"23","author":"X Bai","year":"2017","unstructured":"Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang X, et al. MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: a retrospective study of 2, 793 cases. Clin Cancer Res. 2017;23(20):6120\u201327. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0980.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"8201_CR6","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMra2034861","volume":"384","author":"BD Curti","year":"2021","unstructured":"Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384(23):2229\u201340. https:\/\/doi.org\/10.1056\/NEJMra2034861.","journal-title":"N Engl J Med"},{"issue":"1","key":"8201_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bjd\/ljac005","volume":"188","author":"L Zhou","year":"2023","unstructured":"Zhou L, Shao L, Gao S, Cui C, Chi Z, Sheng X, et al. Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy. Br J Dermatol. 2023;188(1):112\u201321. https:\/\/doi.org\/10.1093\/bjd\/ljac005.","journal-title":"Br J Dermatol"},{"issue":"9","key":"8201_CR8","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","volume":"31","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Namikawa K, Yoshino K, Yoshikawa S, Uchi H, Goto K, et al. Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients. Ann Oncol. 2020;31(9):1198\u2013206. https:\/\/doi.org\/10.1016\/j.annonc.2020.05.031.","journal-title":"Ann Oncol"},{"issue":"4","key":"8201_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.21147\/j.issn.1000-9604.2025.04.09","volume":"37","author":"H Zhao","year":"2025","unstructured":"Zhao H, Tian J, Li H, Lai B. A comparative transcriptomic analysis at single-cell resolution reveals acral melanoma features distinct from cutaneous melanoma. Chin J Cancer Res. 2025;37(4):558\u201374. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.04.09.","journal-title":"Chin J Cancer Res"},{"issue":"10","key":"8201_CR10","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-21-3145","volume":"28","author":"J Li","year":"2022","unstructured":"Li J, Smalley I, Chen Z, Wu JY, Phadke MS, Teer JK, et al. Single-cell Characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy. Clin Cancer Res. 2022;28(10):2131\u201346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3145.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8201_CR11","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1038\/s41467-022-34877-3","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Shen H, Yang T, Li T, Liu X, Wang J, et al. A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nat Commun. 2022;13(1):7250. https:\/\/doi.org\/10.1038\/s41467-022-34877-3.","journal-title":"Nat Commun"},{"issue":"1","key":"8201_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","volume":"26","author":"AU Kabir","year":"2026","unstructured":"Kabir AU, Subramanian M, Kwon Y, Choi K. Linking tumour angiogenesis and tumour immunity. Nat Rev Immunol. 2026;26(1):35\u201351. https:\/\/doi.org\/10.1038\/s41577-025-01211-z.","journal-title":"Nat Rev Immunol"},{"issue":"8082","key":"8201_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41586-025-09303-5","volume":"645","author":"J Heide","year":"2025","unstructured":"Heide J, Bilecz AJ, Patnaik S, Allega MF, Donle L, Yang K, et al. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. Nature. 2025;645(8082):1051\u201359. https:\/\/doi.org\/10.1038\/s41586-025-09303-5.","journal-title":"Nature"},{"issue":"8024","key":"8201_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","volume":"632","author":"X Pan","year":"2024","unstructured":"Pan X, Li X, Dong L, Liu T, Zhang M, Zhang L, et al. Tumour vasculature at single-cell resolution. Nature. 2024;632(8024):429\u201336. https:\/\/doi.org\/10.1038\/s41586-024-07698-1.","journal-title":"Nature"},{"issue":"9","key":"8201_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s43018-024-00807-z","volume":"5","author":"X Chu","year":"2024","unstructured":"Chu X, Li X, Zhang Y, Dang G, Miao Y, Xu W, et al. Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms. Nat Cancer. 2024;5(9):1409\u201326. https:\/\/doi.org\/10.1038\/s43018-024-00807-z.","journal-title":"Nat Cancer"},{"issue":"7","key":"8201_CR16","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247\u201376. https:\/\/doi.org\/10.1038\/s41596-020-0336-2.","journal-title":"Nat Protoc"},{"issue":"3","key":"8201_CR17","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. The Innov. 2021;2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"The Innov"},{"issue":"1","key":"8201_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"8201_CR19","doi-asserted-by":"publisher","unstructured":"Love NR, Williams C, Killingbeck EE, Merleev A, Saffari DM, Yu L, et al. Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors. Sci Adv. 2024;10(28):eadm 8206. https:\/\/doi.org\/10.1126\/sciadv.adm8206.","DOI":"10.1126\/sciadv.adm8206"},{"issue":"4","key":"8201_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu T, Wang Z, Pe\u2019er D, Danko CG. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat Cancer. 2022;3(4):505\u201317. https:\/\/doi.org\/10.1038\/s43018-022-00356-3.","journal-title":"Nat Cancer"},{"issue":"4","key":"8201_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cac2.12651","volume":"45","author":"A Stubenvoll","year":"2025","unstructured":"Stubenvoll A, Schmidt M, Moeller J, Chango MAL, Schultz C, Antoniadou O, et al. Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity. Cancer Commun (Lond). 2025;45(4):465\u201370. https:\/\/doi.org\/10.1002\/cac2.12651.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"8201_CR22","doi-asserted-by":"publisher","first-page":"111994","DOI":"10.1016\/j.celrep.2023.111994","volume":"42","author":"J Wiedemann","year":"2023","unstructured":"Wiedemann J, Billi AC, Bocci F, Kashgari G, Xing E, Tsoi LC, et al. Differential cell composition and split epidermal differentiation in human palm, sole, and hip skin. Cell Rep. 2023;42(1):111994. https:\/\/doi.org\/10.1016\/j.celrep.2023.111994.","journal-title":"Cell Rep"},{"issue":"1","key":"8201_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41467-021-27801-8","volume":"13","author":"G Theocharidis","year":"2022","unstructured":"Theocharidis G, Thomas BE, Sarkar D, Mumme HL, Pilcher WJR, Dwivedi B, et al. Single cell transcriptomic landscape of diabetic foot ulcers. Nat Commun. 2022;13(1):181. https:\/\/doi.org\/10.1038\/s41467-021-27801-8.","journal-title":"Nat Commun"},{"issue":"9","key":"8201_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/jci.insight.152765","volume":"7","author":"SJ Wolf","year":"2022","unstructured":"Wolf SJ, Audu CO, Joshi A, DenDekker A, Melvin WJ, Davis FM, et al. IFN-\u03ba is critical for normal wound repair and is decreased in diabetic wounds. JCI Insight. 2022;7(9):7. https:\/\/doi.org\/10.1172\/jci.insight.152765.","journal-title":"JCI Insight"},{"issue":"1","key":"8201_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-020-0922-4","volume":"3","author":"L Sole-Boldo","year":"2020","unstructured":"Sole-Boldo L, Raddatz G, Schutz S, Mallm JP, Rippe K, Lonsdorf AS, et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol. 2020;3(1):188. https:\/\/doi.org\/10.1038\/s42003-020-0922-4.","journal-title":"Commun Biol"},{"issue":"7","key":"8201_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41423-025-01297-4","volume":"22","author":"Z Shen","year":"2025","unstructured":"Shen Z, Meng X, Rautela J, Chopin M, Huntington ND. Adjusting the scope of natural killer cells in cancer therapy. Cell Mol Immunol. 2025;22(7):699\u2013711. https:\/\/doi.org\/10.1038\/s41423-025-01297-4.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"8201_CR27","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"R Akbani","year":"2015","unstructured":"Akbani R, Akdemir K, Aksoy B, Albert M, Ally A, Amin S, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681\u201396. https:\/\/doi.org\/10.1016\/j.cell.2015.05.044.","journal-title":"Cell"},{"issue":"1","key":"8201_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41467-022-28566-4","volume":"13","author":"F Farshidfar","year":"2022","unstructured":"Farshidfar F, Rhrissorrakrai K, Levovitz C, Peng C, Knight J, Bacchiocchi A, et al. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat Commun. 2022;13(1):898. https:\/\/doi.org\/10.1038\/s41467-022-28566-4.","journal-title":"Nat Commun"},{"key":"8201_CR29","doi-asserted-by":"publisher","first-page":"1441730","DOI":"10.3389\/fimmu.2024.1441730","volume":"15","author":"K Murakami","year":"2024","unstructured":"Murakami K, Ganguly S. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy. Front Immunol. 2024;15:1441730. https:\/\/doi.org\/10.3389\/fimmu.2024.1441730.","journal-title":"Front Immunol"},{"issue":"2","key":"8201_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccell.2023.12.008","volume":"42","author":"J Wienke","year":"2024","unstructured":"Wienke J, Visser LL, Kholosy WM, Keller KM, Barisa M, Poon E, et al. Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy. Cancer Cell. 2024;42(2):283\u2013300.e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.008.","journal-title":"Cancer Cell"},{"issue":"6","key":"8201_CR31","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu Y, Dai E, Li Y, Han G, Pei G, Ingram DR, et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med. 2023;29(6):1550\u201362. https:\/\/doi.org\/10.1038\/s41591-023-02371-y.","journal-title":"Nat Med"},{"issue":"1","key":"8201_CR32","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1038\/s41467-025-61196-0","volume":"16","author":"V Picant","year":"2025","unstructured":"Picant V, Revol-Bauz L, Tonon L, Casini T, Voissiere A, Poujol D, et al. Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features. Nat Commun. 2025;16(1):6135. https:\/\/doi.org\/10.1038\/s41467-025-61196-0.","journal-title":"Nat Commun"},{"issue":"19","key":"8201_CR33","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang F, Li J, Qi L, Liu D, Bo Y, Qin S, et al. A pan-cancer single-cell panorama of human natural killer cells. Cell. 2023;186(19):4235\u201351.e20. https:\/\/doi.org\/10.1016\/j.cell.2023.07.034.","journal-title":"Cell"},{"issue":"1","key":"8201_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, He S, Wang XL, Peng W, Chen QY, Chi DM, et al. Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution. Nat Commun. 2021;12(1):741. https:\/\/doi.org\/10.1038\/s41467-021-21043-4.","journal-title":"Nat Commun"},{"issue":"6","key":"8201_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/HEP.0000000000000673","volume":"79","author":"K Li","year":"2024","unstructured":"Li K, Zhang R, Wen F, Zhao Y, Meng F, Li Q, et al. Single-cell dissection of the multicellular ecosystem and molecular features underlying microvascular invasion in HCC. Hepatology. 2024;79(6):1293\u2013309. https:\/\/doi.org\/10.1097\/HEP.0000000000000673.","journal-title":"Hepatology"},{"issue":"5","key":"8201_CR36","first-page":"345","volume":"21","author":"E Balogh","year":"2019","unstructured":"Balogh E, Biniecka M, Fearon U, Veale DJ, Szekanecz Z. Angiogenesis in inflammatory arthritis. Isr Med Assoc J. 2019;21(5):345\u201352.","journal-title":"Isr Med Assoc J"},{"issue":"18","key":"8201_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1172\/JCI179860","volume":"134","author":"ZJ Li","year":"2024","unstructured":"Li ZJ, He B, Domenichini A, Satiaputra J, Wood KH, Lakhiani DD, et al. Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models. J Clin Investigation. 2024;134(18):134. https:\/\/doi.org\/10.1172\/JCI179860.","journal-title":"J Clin Investigation"},{"issue":"5","key":"8201_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s44321-025-00222-6","volume":"17","author":"B He","year":"2025","unstructured":"He B, Wood KH, Li ZJ, Ermer JA, Li J, Bastow ER, et al. Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity. EMBO Mol Med. 2025;17(5):1071\u2013100. https:\/\/doi.org\/10.1038\/s44321-025-00222-6.","journal-title":"EMBO Mol Med"},{"issue":"385","key":"8201_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1126\/scitranslmed.aak9679","volume":"9","author":"E Allen","year":"2017","unstructured":"Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, et al. Combined antiangiogenic and anti\u2013PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9(385):9. https:\/\/doi.org\/10.1126\/scitranslmed.aak9679.","journal-title":"Sci Transl Med"},{"issue":"11","key":"8201_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","volume":"25","author":"E Lanitis","year":"2025","unstructured":"Lanitis E, Irving M, Coukos G. Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy. Nat Rev Immunol. 2025;25(11):831\u201346. https:\/\/doi.org\/10.1038\/s41577-025-01187-w.","journal-title":"Nat Rev Immunol"},{"key":"8201_CR41","doi-asserted-by":"publisher","unstructured":"Howell R, Davies J, Clarke MA, Appios A, Mesquita I, Jayal Y, et al. Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling. Sci Adv. 2023;9: eadd 1992.15). https:\/\/doi.org\/10.1126\/sciadv.add1992.","DOI":"10.1126\/sciadv.add1992"},{"issue":"8","key":"8201_CR42","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, Wu W, Lei K, Zhang C, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370\u201385.e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006.","journal-title":"Cancer Cell"},{"key":"8201_CR43","doi-asserted-by":"publisher","unstructured":"Love NR, Williams C, Killingbeck EE, Merleev A, Saffari Doost M, Yu L, et al. Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors. Sci Adv. 2024;10(28):eadm 8206. https:\/\/doi.org\/10.1126\/sciadv.adm8206.","DOI":"10.1126\/sciadv.adm8206"},{"issue":"2","key":"8201_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, et al. Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/Anti-CTLA-4 Combined therapy. Cancer Cell. 2019;35(2):238\u201355.e6. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.003.","journal-title":"Cancer Cell"},{"key":"8201_CR45","doi-asserted-by":"crossref","unstructured":"Augustin RC, Newman S, Li A, Joy M, Lyons M, Pham MP, et al. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. J Immunother Cancer. 2023;11.","DOI":"10.1101\/2023.08.24.554717"},{"issue":"5","key":"8201_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10051006","volume":"10","author":"Z Fu","year":"2021","unstructured":"Fu Z, Mowday AM, Smaill JB, Hermans IF, Patterson AV. Tumour hypoxia-mediated immunosuppression: mechanisms and therapeutic approaches to improve cancer immunotherapy. Cells. 2021;10(5):10. https:\/\/doi.org\/10.3390\/cells10051006.","journal-title":"Cells"},{"issue":"1","key":"8201_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","volume":"179","author":"M Harel","year":"2019","unstructured":"Harel M, Ortenberg R, Varanasi SK, Mangalhara KC, Mardamshina M, Markovits E, et al. Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence. Cell. 2019;179(1):236\u201350.e18. https:\/\/doi.org\/10.1016\/j.cell.2019.08.012.","journal-title":"Cell"},{"key":"8201_CR48","doi-asserted-by":"publisher","unstructured":"Maurer K, Park CY, Mani S, Borji M, Raths F, Gouin KH 3rd, et al. Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy. Sci Immunol. 2025;10(103):eadr 0782. https:\/\/doi.org\/10.1126\/sciimmunol.adr0782.","DOI":"10.1126\/sciimmunol.adr0782"},{"issue":"1","key":"8201_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-025-03517-1","volume":"44","author":"H Sun","year":"2025","unstructured":"Sun H, Shi C, Fang G, Guo Q, Du Z, Chen G, et al. Functional tumor-reactive CD8 + T cells in pancreatic cancer. J Exp Clin Cancer Res. 2025;44(1):253. https:\/\/doi.org\/10.1186\/s13046-025-03517-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8201_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Sig Transduct Target Ther. 2023;8(1):198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8201_CR51","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1038\/s41467-025-62475-6","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Yan S, Wu X, Miao Q, Zhang D, Mai W, et al. Pericytes promote metastasis by regulating tumor local vascular tone and hemodynamics. Nat Commun. 2025;16(1):7115. https:\/\/doi.org\/10.1038\/s41467-025-62475-6.","journal-title":"Nat Commun"},{"issue":"16_suppl","key":"8201_CR52","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1200\/JCO.2025.43.16_suppl.9512","volume":"43","author":"L Mao","year":"2025","unstructured":"Mao L, Li C, Dai J, Wei X, Gu J, Du Y, et al. Neoadjuvant camrelizumab plus apatinib and temozolomide for resectable stage II\/III acral melanoma: The CAP 03-NEO trial. 2025. J Retailing Clin Oncol. 2025;43(16_suppl):9512\u20139512. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.9512.","journal-title":"J Retailing Clin Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08201-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:50:39Z","timestamp":1782949839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08201-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8201"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08201-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"838"}}